BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2435113)

  • 1. Depression and Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Sano M; Cote L
    Adv Neurol; 1987; 45():451-5. PubMed ID: 2435113
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biochemical features of depression in Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Cote L; Frantz A; Dyrenfurth I
    Am J Psychiatry; 1986 Jun; 143(6):756-9. PubMed ID: 2424323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of depression reflected in pituitary - thyroid and pituitary - adrenal endocrine changes.
    Agren H; Wide L
    Psychoneuroendocrinology; 1982; 7(4):309-27. PubMed ID: 6188184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 5. TRH stimulation test and depression.
    Peabody CA; Whiteford HA; Warner MD; Faull KF; Barchas JD; Berger PA
    Psychiatry Res; 1987 Sep; 22(1):21-8. PubMed ID: 2443941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological aspects of suicide].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1983; 83(1):7-12. PubMed ID: 6193681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test in Parkinson's disease.
    Pfeiffer RF; Hsieh HH; Diercks MJ; Glaeske C; Jefferson A; Cheng SC
    Adv Neurol; 1987; 45():439-42. PubMed ID: 3825723
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic tests in depression.
    Roy A; Pickar D; Paul S
    Psychosomatics; 1984 Jun; 25(6):443-7, 451. PubMed ID: 6204353
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
    Przuntek H; Kuhn W
    Adv Neurol; 1990; 53():445-9. PubMed ID: 1700583
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; MÃ¥rtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroendocrine and neurochemical measurements in depression.
    Davis KL; Hollister LE; Mathé AA; Davis BM; Rothpearl AB; Faull KF; Hsieh JY; Barchas JD; Berger PA
    Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine changes in depression.
    Joyce PR
    Aust N Z J Psychiatry; 1985 Jun; 19(2):120-7. PubMed ID: 2413836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective disorders: biological aspects.
    Ban TA
    Acta Neurol (Napoli); 1985 Apr; 7(2):129-34. PubMed ID: 2409751
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
    Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value and limits of conducting several neuro-endocrine tests in the diagnosis of depressive states].
    Schmitt L; Granier F; Girard M; Zarouk B; Escande M
    Ann Med Psychol (Paris); 1985 Feb; 143(2):166-74. PubMed ID: 3929664
    [No Abstract]   [Full Text] [Related]  

  • 18. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory diagnosis of depressive disorders].
    Linkowski P
    Rev Med Brux; 1983 Apr; 4(4):229-33. PubMed ID: 6410481
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychoneuroendocrinology of depression.
    Brown GM
    Psychiatr J Univ Ott; 1989 Jun; 14(2):344-8; discussion 349-51. PubMed ID: 2503840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.